The writer is chief executive of UCL Business
Eyebrows were raised at the Labour party’s conference in Liverpool this week when I said that the chancellor, with all eyes on next month’s Budget, should look at life sciences for quick wins.
We shouldn’t sugarcoat Merck and AstraZeneca’s retreat from UK investment. But as leader of UCL’s technology transfer company, which takes the university’s most promising medical research and deep-tech inventions from lab to market, I remain optimistic about the UK being a world leader in health innovations.
您已閱讀14%（546字），剩余86%（3351字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。